Jane Street Group, LLC Enanta Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 23,176 shares of ENTA stock, worth $198,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,176
Previous 28,683 19.2%
Holding current value
$198,386
Previous $372,000 35.48%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.05 - $16.54 $55,345 - $91,085
-5,507 Reduced 19.2%
23,176 $240,000
Q2 2024

Aug 14, 2024
BUY
$11.43 - $17.02 $88,753 - $132,160
7,765 Added 37.12%
28,683 $372,000
Q1 2024

May 15, 2024
SELL
$10.08 - $17.46 $539,501 - $934,494
-53,522 Reduced 71.9%
20,918 $365,000
Q4 2023

Feb 14, 2024
SELL
$8.18 - $10.78 $569,647 - $750,708
-69,639 Reduced 48.33%
74,440 $700,000
Q3 2023

Nov 14, 2023
BUY
$11.09 - $22.13 $1.49 Million - $2.97 Million
134,360 Added 1382.45%
144,079 $1.61 Million
Q2 2023

Aug 14, 2023
SELL
$20.68 - $39.85 $216,457 - $417,109
-10,467 Reduced 51.85%
9,719 $207,000
Q1 2023

May 15, 2023
BUY
$38.82 - $54.59 $783,620 - $1.1 Million
20,186 New
20,186 $816,000
Q1 2022

May 17, 2022
SELL
$56.06 - $74.11 $176,981 - $233,965
-3,157 Closed
0 $0
Q4 2021

Feb 15, 2022
SELL
$60.19 - $97.37 $355,301 - $574,775
-5,903 Reduced 65.15%
3,157 $236,000
Q2 2021

Aug 16, 2021
BUY
$43.76 - $53.11 $396,465 - $481,176
9,060 New
9,060 $399,000
Q1 2021

May 18, 2021
SELL
$41.69 - $54.95 $198,152 - $261,177
-4,753 Closed
0 $0
Q4 2020

Feb 17, 2021
SELL
$41.16 - $47.47 $41,736 - $48,134
-1,014 Reduced 17.58%
4,753 $200,000
Q3 2020

Nov 17, 2020
BUY
$43.36 - $53.53 $70,763 - $87,360
1,632 Added 39.47%
5,767 $264,000
Q2 2020

Aug 17, 2020
BUY
$46.37 - $57.58 $191,739 - $238,093
4,135 New
4,135 $208,000
Q1 2020

May 15, 2020
SELL
$40.22 - $62.0 $194,101 - $299,212
-4,826 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$57.95 - $66.61 $61,079 - $70,206
-1,054 Reduced 17.93%
4,826 $298,000
Q3 2019

Nov 14, 2019
BUY
$60.08 - $88.17 $205,353 - $301,365
3,418 Added 138.83%
5,880 $353,000
Q2 2019

Aug 15, 2019
BUY
$81.3 - $97.35 $200,160 - $239,675
2,462 New
2,462 $208,000
Q1 2019

May 16, 2019
SELL
$69.08 - $105.66 $370,545 - $566,760
-5,364 Closed
0 $0
Q4 2018

Feb 15, 2019
BUY
$65.41 - $84.65 $350,859 - $454,062
5,364 New
5,364 $380,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $177M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email